Thu, January 9, 2025
[ Thu, Jan 09th 2025 ]: Forbes
Where Should Your Money Be In 2025?
[ Thu, Jan 09th 2025 ]: LancasterOnline
Lampeter-Strasburg administrator outlines plan to implement new state science standards
[ Thu, Jan 09th 2025 ]: scrippsnews
Rideable luggage, motorized surfboards, and more on display at CES 2025
[ Thu, Jan 09th 2025 ]: IFLScience
"Quantum Refrigerator" Is A Brand New Way To Reset Quantum Computers
[ Thu, Jan 09th 2025 ]: Impacts
Explore the Best Exhibitions in Madrid in 2025
[ Thu, Jan 09th 2025 ]: techxplore
Building better batteries: Researchers untangle t .. ithium that develop inside rechargeable batteries
[ Thu, Jan 09th 2025 ]: Techopedia
What Is Willow Quantum Chip? Key Capabilities & Multiverse Debate
[ Thu, Jan 09th 2025 ]: Forbes
How Storytelling Boosts Your STEM Job Interview Success
[ Thu, Jan 09th 2025 ]: IFLScience
Why The USA Almost Had A Different Capital City
[ Thu, Jan 09th 2025 ]: timesnownews
Nothing Phone 3 Launch Date, Price In India, Design, Specs, Latest Leaks, What To Expect This Year
[ Thu, Jan 09th 2025 ]: MSN
AI-guided endoscope offers real-time precision during cancer surgery
[ Thu, Jan 09th 2025 ]: MSN
Innovative University of Derby and Sperry Rail inspection project using AI gets underway
[ Thu, Jan 09th 2025 ]: MSN
'Dear Idli Chutney No Sambhar': GATE 2025 aspirants receive bizarre Email from IIT Roorkee
[ Thu, Jan 09th 2025 ]: timesnownews
Valorant Patch 10.00: Major Updates, New Agent Tejo, Map Changes, How To Download And More
[ Thu, Jan 09th 2025 ]: NDTV
Is There A Course To Join ISRO? FAQs On Careers In Indian Space Research Organisation
[ Thu, Jan 09th 2025 ]: MSN
College group fetes 269 graduates in Shah Alam
Wed, January 8, 2025
[ Wed, Jan 08th 2025 ]: stkate
KARE Scholars present undergraduate research at national conference
[ Wed, Jan 08th 2025 ]: CNET
Health Tech Inventions at CES 2025 Could Transform the Future of Personal Wellness
[ Wed, Jan 08th 2025 ]: techxplore
Nuclear fusion could one day be a viable clean en .. , but big engineering challenges stand in the way
[ Wed, Jan 08th 2025 ]: SETI
SETI Institute in the News: December Roundup
[ Wed, Jan 08th 2025 ]: Newsday
Regeneron Science Talent Search scholars: Long Is .. 49 semifinalists, more than any other U.S. region
[ Wed, Jan 08th 2025 ]: Forbes
Top 3 AI Jobs For 2025 And How To Transition Into The Positions
[ Wed, Jan 08th 2025 ]: Firstpost
OpenAI's new O3 reasoning model is freaking out software engineers, developers; Here's why
[ Wed, Jan 08th 2025 ]: MSN
S. Korea to invest 86.2 bln won in developing new technologies to address climate change
[ Wed, Jan 08th 2025 ]: Tuko
Sam Altman's spouse: Meet the ChatGPT founder's husband, Oliver Mulherin
[ Wed, Jan 08th 2025 ]: MSN
V Narayanan: Educational qualifications of the new ISRO chief
[ Wed, Jan 08th 2025 ]: MSN
Science ministry holds talk at CES 2025
[ Wed, Jan 08th 2025 ]: BBC
Key appointments Ghana new president John Mahama make
[ Wed, Jan 08th 2025 ]: MSN
NASA collected potential evidence of life on Mars .. Now it's pitching new plans to retrieve the cache
Tue, January 7, 2025
[ Tue, Jan 07th 2025 ]: Indiatimes
Here are trends in GCCs
[ Tue, Jan 07th 2025 ]: TechRadar
A secret project, a stubborn developer, and a lot .. re's the story behind macOS's Dock as it turns 25
[ Tue, Jan 07th 2025 ]: NASA
2023 Entrepreneurs Challenge Winner Skyline Nav A .. g GPS-Independent Navigation with Computer Vision
[ Tue, Jan 07th 2025 ]: NDTV
IAF Agniveervayu Recruitment 2024: Registration Window Opens, Check Details
[ Tue, Jan 07th 2025 ]: Forbes
20 Cost-Effective IT Projects That Deliver Big Results
[ Tue, Jan 07th 2025 ]: Forbes
A Global Imperative: Confronting The Global Semiconductor Talent Shortage
[ Tue, Jan 07th 2025 ]: Yahoo
America expects too little from kids. We need more 'tiger moms.' | Opinion
[ Tue, Jan 07th 2025 ]: CNET
Top Wellness Trends to Watch in 2025
[ Tue, Jan 07th 2025 ]: IFLScience
Polar Vortex And Polar Jet Stream: What's Behind The Freezing Weather In The US?
[ Tue, Jan 07th 2025 ]: Yahoo
We're using AI for stupid and unnecessary reasons. What if we just stopped? | Opinion
[ Tue, Jan 07th 2025 ]: TradeWinds
Knutsen Tankers and Vard reveal project to design nuclear-powered ships
[ Tue, Jan 07th 2025 ]: MSN
Nvidia CEO Jensen Huang debuts new AI platform to dominate the 'ChatGPT moment' in robotics
[ Tue, Jan 07th 2025 ]: MSN
GATE admit card 2025 OUT at gate2025.iitr.ac.in? Download link, login credentials
[ Tue, Jan 07th 2025 ]: MSN
Here's What to Expect From Alexandria Real Estate's Next Earnings Report
[ Tue, Jan 07th 2025 ]: MSN
Boffins create mega robot nose that can detect killer diseases from patients' breath
[ Tue, Jan 07th 2025 ]: NDTV
Loneliness And Social Isolation Are Linked To Specific Proteins: Study
Mon, January 6, 2025
[ Mon, Jan 06th 2025 ]: MSN
Minot State University uses Artificial Intelligence to improve learning
[ Mon, Jan 06th 2025 ]: MSN
'Data' and three other words that can be pronounced in two ways
[ Mon, Jan 06th 2025 ]: MSN
Pentagon Labels More Chinese Companies as Military in Nature

Vir jumps after Phase 1 data for Sanofi-partnered cancer drug technology

  Copy link into your clipboard //science-technology.news-articles.net/content/2 .. for-sanofi-partnered-cancer-drug-technology.html
  Print publication without navigation Published in Science and Technology on by MSN
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains editorial commentary or bias from the source
Shares of Vir Biotechnology (CIR) climbed ~42% in the premarket on Wednesday after the company posted initial Phase 1 data for two antitumor agents developed using its PRO-XTEN masking technology, in-licensed from Sanofi (NASDAQ:SNY).
The article from MSN discusses Vir Biotechnology's significant stock price increase following the release of promising Phase 1 data for their cancer drug technology, developed in partnership with Sanofi. The drug, VIR-2482, targets the T cell immunoglobulin and mucin domain-3 (TIM-3) receptor, which is involved in immune response regulation. The preliminary results showed that VIR-2482 was well-tolerated and demonstrated biological activity, suggesting potential effectiveness in treating various cancers by enhancing the immune system's ability to fight tumors. This development has not only boosted investor confidence but also highlighted the potential of Vir's innovative approach in immunotherapy, leading to a surge in its stock value.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/science/biochemistry/vir-jumps-after-phase-1-data-for-sanofi-partnered-cancer-drug-technology/ar-AA1xaULT ]


Similar Science and Technology Publications
[ Mon, Dec 02nd 2024 ]: Tim Hastings